CareCloud (CCLD) Financials

CareCloud logo
$2.38 +0.13 (+5.78%)
Closing price 11/18/2026 04:00 PM Eastern
Extended Trading
$2.37 -0.01 (-0.25%)
As of 11/18/2026 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for CareCloud

Annual Income Statements for CareCloud

This table shows CareCloud's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-4.89 -9.55 -7.60 -6.96 -7.26 -23 -11 -10 -64 -4.46 3.89
Consolidated Net Income / (Loss)
-4.69 -8.80 -5.57 -2.14 -0.87 -8.81 2.84 5.43 -49 7.85 11
Net Income / (Loss) Continuing Operations
-4.69 -8.80 -5.57 -2.14 -0.87 -8.81 2.84 5.43 -49 7.85 11
Total Pre-Tax Income
-4.55 -8.60 -5.50 -2.30 -0.68 -8.71 2.99 5.61 -49 8.01 11
Total Operating Income
-4.46 -7.90 -4.52 -2.54 0.07 -8.27 3.53 6.61 -47 9.12 11
Total Gross Profit
23 24 32 51 64 105 140 139 46 111 120
Total Revenue
23 24 32 51 64 105 140 139 117 111 120
Operating Revenue
23 24 32 51 64 105 140 139 117 111 120
Total Cost of Revenue
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 71 0.00 0.00
Total Operating Expenses
28 32 36 53 64 113 136 132 93 102 109
Selling, General & Admin Expense
12 12 12 16 18 23 24 108 21 77 83
Marketing Expense
0.47 1.22 1.11 1.61 1.52 6.58 8.79 9.79 9.65 6.23 4.82
Research & Development Expense
0.66 0.90 1.08 1.03 0.87 9.31 4.41 4.40 4.74 3.78 6.38
Depreciation Expense
4.60 5.11 4.30 2.85 3.01 9.91 12 12 14 14 15
Restructuring Charge
- 0.00 0.28 0.00 0.22 - - 1.14 1.11 0.60 0.15
Total Other Income / (Expense), net
-0.09 -0.70 -0.98 0.24 -0.75 -0.44 -0.54 -1.00 -1.92 -1.11 -0.35
Interest Expense
0.29 0.68 1.32 0.35 0.38 0.49 0.46 0.41 1.19 0.90 0.29
Interest & Investment Income
0.03 0.04 0.02 0.10 0.26 0.04 0.02 0.04 0.15 0.09 0.21
Other Income / (Expense), net
0.17 -0.05 0.33 0.49 -0.63 0.01 -0.10 -0.64 -0.88 -0.30 -0.27
Income Tax Expense
0.14 0.20 0.07 -0.16 0.19 0.10 0.16 0.18 -0.36 0.16 0.20
Preferred Stock Dividends Declared
0.21 0.75 2.03 4.82 6.39 14 14 16 16 12 6.91
Basic Earnings per Share
- ($0.95) ($0.69) ($0.59) ($0.60) ($1.79) ($0.77) ($0.67) ($4.11) ($0.28) $0.10
Weighted Average Basic Shares Outstanding
9.73M 10.04M 11.01M 11.72M 12.09M 12.68M 14.54M 15.11M 15.67M 16.15M 37.79M
Diluted Earnings per Share
- ($0.95) ($0.69) ($0.59) ($0.60) ($1.79) - ($0.67) ($4.11) ($0.28) $0.10
Weighted Average Diluted Shares Outstanding
9.73M 10.04M 11.01M 11.72M 12.09M 12.68M 14.54M 15.11M 15.67M 16.15M 37.95M
Weighted Average Basic & Diluted Shares Outstanding
9.73M 10.04M 11.01M 11.72M 12.09M 12.68M 14.54M 15.51M 16.12M 42.32M 42.49M

Quarterly Income Statements for CareCloud

This table shows CareCloud's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Total Costs & Expenses
- - - - - - 28 - - - 27
Net Income / (Loss) Attributable to Common Shareholders
-1.55 -2.25 -0.67 0.01 -0.86 1.54 1.70 1.52 -0.44 0.18 4.19
Consolidated Net Income / (Loss)
-0.24 1.67 3.12 3.30 1.95 2.90 3.06 2.89 0.92 1.12 4.73
Net Income / (Loss) Continuing Operations
-0.24 1.67 3.12 3.30 1.95 2.90 3.06 2.89 0.92 1.12 4.73
Total Pre-Tax Income
-0.20 1.71 3.16 3.34 1.99 2.94 3.10 2.96 0.97 1.22 4.85
Total Operating Income
0.13 2.27 3.27 3.46 2.02 3.00 3.21 3.12 1.00 1.86 6.58
Total Gross Profit
11 13 13 74 28 13 15 81 31 14 17
Total Revenue
26 28 29 28 28 27 31 34 31 32 34
Operating Revenue
26 28 29 28 28 27 31 34 31 32 34
Total Cost of Revenue
15 15 15 -46 0.00 14 16 -46 0.00 17 17
Operating Cost of Revenue
15 15 15 - - 14 16 - - 17 17
Total Operating Expenses
11 11 9.86 71 26 9.90 12 77 30 13 10
Selling, General & Admin Expense
3.72 4.03 4.38 65 20 4.36 4.89 69 22 5.37 4.95
Marketing Expense
1.77 1.66 1.38 1.42 1.13 1.12 1.12 1.45 1.41 1.30 1.31
Research & Development Expense
0.91 1.06 0.80 1.01 1.24 1.02 1.58 2.54 2.42 2.19 1.05
Depreciation Expense
3.93 3.71 3.24 3.26 3.34 3.38 4.02 4.22 4.04 3.73 3.17
Restructuring Charge
0.32 0.12 0.07 0.09 0.11 0.02 0.02 - 0.00 0.00 0.00
Other Special Charges / (Income)
- - - - 0.00 0.00 0.00 - 0.06 -0.03 -0.03
Total Other Income / (Expense), net
-0.33 -0.56 -0.10 -0.12 -0.03 -0.05 -0.11 -0.16 -0.03 -0.64 -1.72
Interest Expense
0.37 0.29 0.18 0.07 0.06 0.07 0.15 0.01 0.06 0.82 1.80
Interest & Investment Income
0.03 0.02 0.02 0.02 0.04 0.05 0.10 0.02 0.01 0.07 0.08
Other Income / (Expense), net
0.01 -0.29 0.06 -0.07 -0.01 -0.04 -0.06 -0.16 0.02 0.10 -0.00
Income Tax Expense
0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.07 0.05 0.10 0.13
Preferred Stock Dividends Declared
1.31 3.92 3.79 3.29 2.81 1.37 1.37 1.37 1.37 0.94 0.54
Basic Earnings per Share
($0.10) ($0.14) ($0.04) - ($0.04) $0.04 $0.04 $0.06 ($0.01) $0.00 $0.10
Weighted Average Basic Shares Outstanding
16.01M 16.13M 16.20M 16.15M 23.81M 42.32M 42.37M 37.79M 42.47M 42.49M 42.53M
Diluted Earnings per Share
($0.10) ($0.14) ($0.04) - ($0.04) $0.04 $0.04 $0.06 ($0.01) $0.00 $0.10
Weighted Average Diluted Shares Outstanding
16.01M 16.13M 16.20M 16.15M 23.81M 42.32M 42.37M 37.95M 42.47M 42.49M 42.53M
Weighted Average Basic & Diluted Shares Outstanding
16.12M 16.21M 16.24M 42.32M 42.32M 42.32M 42.40M 42.49M 42.49M 42.49M 42.55M

Annual Cash Flow Statements for CareCloud

This table details how cash moves in and out of CareCloud's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
6.99 -4.56 0.89 10 4.88 0.93 -11 1.96 -8.97 1.81 -1.53
Net Cash From Operating Activities
-1.88 -0.89 0.28 6.81 7.62 -0.89 13 21 15 21 29
Net Cash From Continuing Operating Activities
-1.88 -0.89 0.28 6.81 7.62 -0.89 13 21 15 21 29
Net Income / (Loss) Continuing Operations
-4.69 -8.80 -5.57 -2.14 -0.87 -8.81 2.84 5.43 -49 7.85 11
Consolidated Net Income / (Loss)
-4.69 -8.80 -5.57 -2.14 -0.87 -8.81 2.84 5.43 -49 7.85 11
Depreciation Expense
4.60 5.11 4.30 2.91 3.07 10 13 12 15 14 15
Amortization Expense
- - - 0.00 1.89 2.89 3.57 3.29 2.15 1.99 1.77
Non-Cash Adjustments To Reconcile Net Income
0.79 2.43 2.33 2.48 5.06 7.49 6.72 7.19 48 1.63 1.09
Changes in Operating Assets and Liabilities, net
-2.58 0.37 -0.79 3.56 -1.53 -13 -12 -7.07 -1.03 -5.31 -0.30
Net Cash From Investing Activities
-0.60 -3.83 -0.90 -14 -4.16 -31 -23 -12 -12 -7.41 -25
Net Cash From Continuing Investing Activities
-0.60 -3.83 -0.90 -14 -4.16 -31 -23 -12 -12 -7.41 -25
Purchase of Property, Plant & Equipment
-0.42 -0.46 -0.70 -1.03 -2.56 -7.75 -11 -2.59 -3.06 -1.70 -4.78
Acquisitions
-0.18 -3.37 -0.21 -13 -1.60 -24 -13 - - 0.00 -17
Other Investing Activities, net
- - - - - - - -9.18 -8.55 -5.71 -3.25
Net Cash From Financing Activities
9.50 0.15 1.84 18 1.42 33 -0.52 -7.65 -13 -11 -5.61
Net Cash From Continuing Financing Activities
9.50 0.15 1.84 18 1.42 33 -0.52 -7.65 -13 -11 -5.61
Repayment of Debt
-12 -7.58 -24 -12 -0.48 -20 -19 -27 -14 -11 -9.96
Payment of Dividends
-0.05 -0.71 -1.49 -4.10 -6.11 -11 -14 -15 -14 0.00 -6.30
Issuance of Debt
17 7.91 9.20 11 0.00 20 26 26 15 0.00 11
Other Financing Activities, net
0.00 -0.20 -0.34 -0.48 -1.58 0.93 4.31 -2.20 -1.52 -0.58 -0.15
Effect of Exchange Rate Changes
-0.03 0.01 -0.34 - - -0.13 -0.25 0.23 0.47 -0.17 0.06
Cash Interest Paid
0.26 0.45 0.61 0.06 0.07 0.17 0.10 0.16 0.93 0.68 0.23
Cash Income Taxes Paid
0.01 0.05 0.01 0.04 0.12 0.09 0.28 0.15 0.14 0.16 0.25

Quarterly Cash Flow Statements for CareCloud

This table details how cash moves in and out of CareCloud's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
0.81 -1.52 0.17 2.36 1.66 3.64 -5.37 -1.46 0.24 9.54 -8.76
Net Cash From Operating Activities
4.07 4.28 7.07 5.23 5.11 7.41 7.37 8.68 3.61 7.07 5.64
Net Cash From Continuing Operating Activities
4.07 4.28 7.07 5.23 5.11 7.41 7.37 8.68 3.61 7.07 5.64
Net Income / (Loss) Continuing Operations
-0.24 1.67 3.12 3.30 1.95 2.90 3.06 2.89 0.92 1.12 4.73
Consolidated Net Income / (Loss)
-0.24 1.67 3.12 3.30 1.95 2.90 3.06 2.89 0.92 1.12 4.73
Depreciation Expense
4.02 3.80 3.32 3.33 3.41 3.45 4.08 4.27 4.09 3.77 3.23
Amortization Expense
0.51 0.50 0.49 0.49 0.48 0.42 0.42 0.45 0.46 0.43 0.42
Non-Cash Adjustments To Reconcile Net Income
-0.88 1.11 0.68 0.71 0.18 0.84 0.48 -0.41 0.43 0.28 1.76
Changes in Operating Assets and Liabilities, net
0.65 -2.81 -0.55 -2.60 -0.90 -0.20 -0.67 1.48 -2.29 1.47 -4.49
Net Cash From Investing Activities
-1.87 -1.60 -1.67 -2.26 -1.51 -1.99 -18 -3.34 -1.23 -2.01 -2.14
Net Cash From Continuing Investing Activities
-1.87 -1.60 -1.67 -2.26 -1.51 -1.99 -18 -3.34 -1.23 -2.01 -2.14
Purchase of Property, Plant & Equipment
-0.30 -0.13 -0.33 -0.94 -0.62 -1.16 -0.87 -2.12 -0.41 -0.53 -0.33
Acquisitions
0.00 - - - -0.04 - -16 -0.47 0.00 -0.68 -0.29
Other Investing Activities, net
-1.57 -1.48 -1.34 -1.32 -0.85 -0.83 -0.83 -0.74 -0.82 -0.80 -1.53
Net Cash From Financing Activities
-1.37 -4.14 -5.17 -0.58 -1.93 -1.76 4.92 -6.84 -2.15 4.47 -12
Net Cash From Continuing Financing Activities
-1.37 -4.14 -5.17 -0.58 -1.93 -1.76 4.92 -6.84 -2.15 4.47 -12
Repayment of Debt
-1.22 -4.11 -5.15 -0.20 -0.18 -0.17 -1.87 -7.74 -0.18 -1.01 -12
Payment of Dividends
0.00 - - - -1.73 -1.59 -1.50 -1.47 -1.92 -4.52 -0.54
Issuance of Debt
- - - - - - - 2.45 - - 0.02
Other Financing Activities, net
-0.15 -0.03 -0.02 -0.38 -0.02 -0.00 -0.05 -0.07 -0.06 -0.56 -0.06
Effect of Exchange Rate Changes
-0.02 -0.06 -0.06 -0.03 -0.01 -0.02 0.05 0.04 0.01 - 0.00
Cash Interest Paid
0.30 0.23 0.12 0.04 0.02 0.03 0.02 0.16 0.02 0.50 0.86
Cash Income Taxes Paid
0.01 0.12 0.02 0.01 0.02 0.13 0.03 0.07 0.01 0.14 0.01

Annual Balance Sheets for CareCloud

This table presents CareCloud's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
27 28 26 48 56 138 141 136 78 72 88
Total Current Assets
11 8.44 8.93 26 31 45 36 35 23 25 26
Cash & Equivalents
8.04 3.48 4.36 14 20 21 9.34 12 3.33 5.15 3.12
Restricted Cash
- - - - - 0.00 1.00 - - 0.00 0.50
Accounts Receivable
2.23 4.34 3.90 7.36 7.01 12 17 15 12 13 15
Inventories, net
- - 0.00 0.44 0.49 0.40 0.50 0.38 0.47 0.57 0.51
Prepaid Expenses
0.62 0.62 0.66 1.19 1.12 7.29 2.97 2.79 2.45 1.96 2.87
Other Current Assets
- - 0.00 2.61 2.39 4.11 4.74 4.40 5.09 4.33 3.66
Plant, Property, & Equipment, net
1.37 1.59 1.39 1.83 2.91 4.92 5.40 5.06 5.32 5.29 7.78
Total Noncurrent Assets
14 18 15 20 22 88 100 96 49 42 54
Goodwill
8.97 12 12 13 13 49 61 61 19 19 31
Intangible Assets
5.38 5.83 2.51 6.63 5.98 30 31 30 25 19 19
Other Noncurrent Operating Assets
0.07 0.28 0.44 0.49 3.88 8.99 7.92 5.76 5.01 3.64 3.68
Total Liabilities & Shareholders' Equity
27 28 26 48 56 138 141 136 78 72 88
Total Liabilities
12 21 5.28 8.75 14 37 43 34 36 22 28
Total Current Liabilities
5.76 16 4.32 8.16 11 29 30 22 23 20 24
Short-Term Debt
3.83 10 0.67 0.80 0.28 0.40 1.34 0.32 0.29 0.31 0.91
Accounts Payable
0.37 1.91 0.99 2.44 3.49 6.46 5.95 5.68 5.80 4.57 6.94
Accrued Expenses
1.29 3.26 1.76 1.60 2.11 8.50 5.09 4.43 5.07 4.95 5.97
Dividends Payable
0.16 0.20 0.75 1.47 1.75 4.24 3.86 4.06 5.43 5.44 0.67
Current Deferred Revenue
0.11 0.10 0.14 0.12 0.02 1.17 1.09 1.39 1.38 1.21 4.15
Current Employee Benefit Liabilities
- - - 1.73 1.84 2.59 4.25 4.25 3.44 1.82 4.14
Other Current Liabilities
- - - 0.00 1.69 4.73 7.05 2.27 1.89 1.29 1.66
Total Noncurrent Liabilities
6.03 5.40 0.95 0.60 2.39 7.73 13 12 13 2.26 3.67
Long-Term Debt
4.90 4.20 0.12 0.22 0.08 0.04 8.02 8.01 10 0.03 0.44
Noncurrent Deferred Revenue
0.53 0.46 0.36 0.21 0.02 0.31 0.34 0.34 0.26 0.39 0.81
Noncurrent Deferred & Payable Income Tax Liabilities
0.17 0.35 0.37 0.16 0.24 1.09 0.45 0.53 - - 0.00
Other Noncurrent Operating Liabilities
0.43 0.39 0.10 0.00 2.04 6.30 4.55 3.21 2.52 1.85 2.42
Commitments & Contingencies
- - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
15 7.07 20 39 43 101 98 102 42 50 60
Total Preferred & Common Equity
15 7.07 20 39 43 101 98 102 42 50 60
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.00
Total Common Equity
15 7.07 20 39 43 101 98 102 42 50 60
Common Stock
25 26 45 65 69 137 131 131 121 121 120
Retained Earnings
-9.15 -18 -24 -24 -25 -34 -31 -26 -74 -67 -56
Treasury Stock
-0.12 -0.66 -0.66 -0.66 -0.66 -0.66 -0.66 -0.66 -0.66 - -0.66
Accumulated Other Comprehensive Income / (Loss)
-0.40 -0.38 -0.72 -1.42 -0.84 -1.00 -1.75 -3.04 -3.87 -4.00 -3.98

Quarterly Balance Sheets for CareCloud

This table presents CareCloud's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
126 77 74 71 74 75 91 87 94 87
Total Current Assets
27 24 24 23 29 31 29 26 34 28
Cash & Equivalents
6.41 4.14 2.62 2.78 6.81 10 4.26 3.35 13 4.64
Restricted Cash
- - - - - - 0.82 0.50 0.00 0.00
Accounts Receivable
12 12 13 12 14 14 15 15 14 17
Inventories, net
0.48 0.48 0.50 0.51 0.61 0.52 0.61 0.43 0.47 0.51
Prepaid Expenses
3.30 2.23 2.91 2.74 2.84 2.59 4.29 3.05 2.76 3.64
Other Current Assets
4.95 5.46 4.80 4.62 4.46 3.96 3.96 3.50 3.43 3.06
Plant, Property, & Equipment, net
5.32 5.44 5.06 4.89 5.32 5.83 6.31 7.46 7.26 6.84
Total Noncurrent Assets
93 47 45 43 40 38 55 53 52 52
Goodwill
61 19 19 19 19 19 30 31 32 32
Intangible Assets
27 23 21 20 17 16 21 17 15 14
Other Noncurrent Operating Assets
5.24 4.75 4.36 3.85 3.55 3.62 3.33 5.24 5.64 5.98
Total Liabilities & Shareholders' Equity
126 77 74 71 74 75 91 87 94 87
Total Liabilities
38 35 31 24 19 19 33 28 76 64
Total Current Liabilities
22 24 23 22 17 16 23 23 33 33
Short-Term Debt
0.49 0.17 0.07 0.51 0.18 0.55 0.93 1.48 0.40 0.26
Accounts Payable
6.24 5.92 5.45 5.57 4.95 4.22 6.69 5.51 6.07 6.20
Accrued Expenses
4.63 6.35 6.62 5.14 5.00 4.91 5.67 5.95 5.94 5.70
Dividends Payable
4.13 5.44 5.44 5.44 1.30 0.71 0.71 0.94 0.39 0.39
Current Deferred Revenue
1.53 1.39 1.22 1.31 1.30 1.23 4.27 4.75 4.51 3.94
Current Employee Benefit Liabilities
3.12 2.77 2.82 2.55 2.87 3.32 3.83 3.48 3.85 3.86
Other Current Liabilities
1.81 1.78 1.62 1.42 1.36 1.29 1.11 1.36 12 12
Total Noncurrent Liabilities
16 12 7.52 2.26 2.43 2.93 9.57 4.93 43 32
Long-Term Debt
12 9.04 5.03 0.03 0.02 0.09 6.73 0.25 38 27
Noncurrent Deferred Revenue
0.42 0.31 0.39 0.33 0.57 0.63 0.73 0.89 0.93 1.02
Noncurrent Deferred & Payable Income Tax Liabilities
0.61 - - - - - - - 0.05 0.10
Other Noncurrent Operating Liabilities
2.79 2.32 2.10 1.90 1.84 2.21 2.11 3.79 3.75 4.03
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
88 41 43 47 54 56 58 58 17 23
Total Preferred & Common Equity
88 41 43 47 54 56 58 58 17 23
Preferred Stock
0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
88 41 43 47 54 56 58 58 17 23
Common Stock
124 121 121 121 124 123 121 118 76 76
Retained Earnings
-31 -75 -73 -70 -65 -62 -59 -55 -54 -49
Treasury Stock
-0.66 -0.66 -0.66 -0.66 -0.66 -0.66 -0.66 -0.66 -0.66 -0.66
Accumulated Other Comprehensive Income / (Loss)
-4.29 -3.84 -3.91 -3.96 -4.06 -4.16 -4.08 -3.95 -3.93 -3.89

Annual Metrics And Ratios for CareCloud

This table displays calculated financial ratios and metrics derived from CareCloud's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
11,066,086.00 10,300,378.00 11,530,591.00 11,829,758.00 12,219,148.00 13,187,221.00 14,874,631.00 15,220,208.00 15,873,120.00 16,239,777.00 42,397,039.00
DEI Adjusted Shares Outstanding
11,066,086.00 10,300,378.00 11,530,591.00 11,829,758.00 12,219,148.00 13,187,221.00 14,874,631.00 15,220,208.00 15,873,120.00 16,239,777.00 42,397,039.00
DEI Earnings Per Adjusted Shares Outstanding
-0.44 -0.93 -0.66 -0.59 -0.59 -1.72 -0.75 -0.66 -4.05 -0.27 0.09
Growth Metrics
- - - - - - - - - - -
Revenue Growth
26.10% 6.12% 29.87% 58.90% 27.49% 63.13% 32.80% -0.55% -15.68% -5.32% 8.72%
EBITDA Growth
122.44% -1,016.27% 103.86% 690.39% 406.81% 8.13% 313.60% 9.62% -243.47% 181.68% 10.94%
EBIT Growth
-2.68% -85.50% 47.32% 51.18% 72.72% -1,381.00% 141.54% 73.99% -903.58% 118.38% 25.56%
NOPAT Growth
-10.32% -77.22% 42.76% 43.84% 102.64% -12,444.78% 157.76% 91.44% -615.21% 127.10% 24.60%
Net Income Growth
-3.95% -87.67% 36.74% 61.57% 59.22% -910.67% 132.18% 91.54% -996.06% 116.13% 37.54%
EPS Growth
0.00% 0.00% 27.37% 14.49% -1.69% -198.33% 0.00% 0.00% -513.43% 93.19% 135.71%
Operating Cash Flow Growth
30.27% 52.76% 131.67% 2,318.84% 11.82% -111.71% 1,594.84% 58.62% -26.90% 33.51% 38.36%
Free Cash Flow Firm Growth
96.44% -1,184.82% 72.81% -406.32% 117.65% -3,418.21% 81.07% 143.58% 169.77% -13.44% -77.09%
Invested Capital Growth
-13.63% 16.72% -5.15% 54.29% -7.20% 240.61% 18.60% 0.96% -46.80% -6.92% 16.33%
Revenue Q/Q Growth
-7.02% 16.49% -1.66% 19.42% -1.16% 18.32% 4.04% -3.43% -3.40% -0.16% 5.41%
EBITDA Q/Q Growth
229.97% -5,001.11% 104.36% -6.41% 35.40% 153.51% 22.96% -13.81% -341.06% 219.86% 1.70%
EBIT Q/Q Growth
9.47% -69.52% 45.79% -16.85% 63.89% -1.59% 3,249.54% -35.31% -1,288.03% 122.92% -3.72%
NOPAT Q/Q Growth
8.50% -69.67% 42.20% -19.44% 104.03% -5.79% 9,648.93% -30.42% -1,762.25% 133.63% -3.23%
Net Income Q/Q Growth
3.99% -57.84% 40.83% -22.51% 51.03% -2.06% 633.08% -35.75% -985.75% 120.06% -3.64%
EPS Q/Q Growth
0.00% 0.00% 34.29% -28.26% 10.45% -8.48% 0.00% 0.00% 0.00% 91.57% 150.00%
Operating Cash Flow Q/Q Growth
26.86% -89.29% 116.46% 7.49% 11.74% 39.27% 25.19% -0.36% -12.99% 7.77% 13.72%
Free Cash Flow Firm Q/Q Growth
0.00% -666.38% 73.14% 9.43% 25.78% -1.72% 13.37% 12.41% 328.31% -42.59% 2,603.58%
Invested Capital Q/Q Growth
-6.00% 26.27% 0.51% -4.85% -2.21% 0.27% 1.63% -1.72% -44.96% 1.42% -4.04%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 39.50% 100.00% 100.00%
EBITDA Margin
1.35% -11.62% 0.35% 1.72% 6.83% 4.53% 14.10% 15.54% -26.45% 22.81% 23.28%
Operating Margin
-19.32% -32.26% -14.22% -5.02% 0.10% -7.87% 2.53% 4.76% -40.25% 8.23% 9.41%
EBIT Margin
-18.58% -32.48% -13.17% -4.05% -0.87% -7.86% 2.46% 4.30% -41.00% 7.96% 9.19%
Profit (Net Income) Margin
-20.31% -35.91% -17.49% -4.23% -1.35% -8.38% 2.03% 3.91% -41.58% 7.08% 8.96%
Tax Burden Percent
103.03% 102.29% 101.23% 93.14% 128.42% 101.18% 94.75% 96.84% 99.26% 98.00% 98.19%
Interest Burden Percent
106.10% 108.12% 131.20% 112.24% 121.68% 105.40% 87.18% 93.91% 102.17% 90.80% 99.27%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 5.25% 3.16% 0.00% 2.00% 1.81%
Return on Invested Capital (ROIC)
-18.37% -32.42% -17.68% -8.02% 0.18% -10.53% 3.60% 6.32% -42.30% 17.10% 20.43%
ROIC Less NNEP Spread (ROIC-NNEP)
-84.21% -86.14% -74.22% -3.15% 6.34% 7.19% 11.20% -58.92% -292.94% 0.44% 301.21%
Return on Net Nonoperating Assets (RNNOA)
-13.72% -47.70% -23.06% 0.79% -2.32% -1.70% -0.75% -0.88% -25.58% 0.06% -0.67%
Return on Equity (ROE)
-32.09% -80.12% -40.74% -7.23% -2.13% -12.23% 2.85% 5.44% -67.88% 17.16% 19.76%
Cash Return on Invested Capital (CROIC)
-3.74% -47.85% -12.40% -50.72% 7.65% -119.75% -13.42% 5.36% 18.79% 24.26% 5.33%
Operating Return on Assets (OROA)
-17.23% -28.92% -15.56% -5.59% -1.07% -8.50% 2.46% 4.31% -44.86% 11.81% 13.92%
Return on Assets (ROA)
-18.83% -31.99% -20.67% -5.85% -1.68% -9.07% 2.03% 3.92% -45.49% 10.51% 13.56%
Return on Common Equity (ROCE)
-32.09% -80.12% -40.74% -7.23% -2.13% -12.23% 2.85% 5.44% -67.88% 17.16% 19.76%
Return on Equity Simple (ROE_SIMPLE)
-31.48% -124.48% -27.48% -5.50% -2.04% -8.70% 2.90% 5.34% -116.68% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-3.12 -5.53 -3.17 -1.78 0.05 -5.79 3.34 6.40 -33 8.94 11
NOPAT Margin
-13.52% -22.58% -9.95% -3.52% 0.07% -5.51% 2.40% 4.61% -28.17% 8.06% 9.24%
Net Nonoperating Expense Percent (NNEP)
65.84% 53.72% 56.53% -4.87% -6.16% -17.72% -7.60% 65.24% 250.63% 16.66% -280.78%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - -63.37% 17.84% 18.09%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 60.50% 0.00% 0.00%
SG&A Expenses to Revenue
51.86% 50.87% 36.90% 32.18% 27.80% 21.70% 17.39% 77.98% 18.34% 69.44% 68.75%
R&D to Revenue
2.86% 3.68% 3.40% 2.04% 1.35% 8.86% 3.16% 3.17% 4.05% 3.41% 5.30%
Operating Expenses to Revenue
119.32% 132.26% 114.22% 105.02% 99.90% 107.87% 97.47% 95.24% 79.75% 91.77% 90.59%
Earnings before Interest and Taxes (EBIT)
-4.29 -7.95 -4.19 -2.05 -0.56 -8.26 3.43 5.97 -48 8.82 11
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
0.31 -2.85 0.11 0.87 4.40 4.76 20 22 -31 25 28
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.89 1.06 1.49 1.16 1.16 1.18 0.96 0.42 0.58 1.19 2.08
Price to Tangible Book Value (P/TBV)
24.58 0.00 5.50 2.29 2.05 5.44 15.77 3.90 0.00 5.00 13.61
Price to Revenue (P/Rev)
0.58 0.30 0.95 0.89 0.77 1.14 0.67 0.31 0.21 0.54 1.03
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 31.81
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 3.14%
Enterprise Value to Invested Capital (EV/IC)
0.89 1.01 1.52 1.17 1.20 1.17 0.92 0.38 0.57 1.08 2.09
Enterprise Value to Revenue (EV/Rev)
0.61 0.76 0.83 0.62 0.47 0.94 0.67 0.28 0.27 0.49 1.01
Enterprise Value to EBITDA (EV/EBITDA)
44.98 0.00 241.46 36.29 6.81 20.83 4.73 1.80 0.00 2.16 4.36
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 27.10 6.50 0.00 6.19 11.04
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 639.33 0.00 27.82 6.06 0.00 6.11 10.98
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 94.19 4.63 3.94 0.00 6.98 1.83 2.01 2.65 4.28
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 15.11 0.00 0.00 7.15 2.12 4.31 42.08
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.59 2.06 0.04 0.03 0.01 0.00 0.10 0.08 0.25 0.01 0.03
Long-Term Debt to Equity
0.33 0.59 0.01 0.01 0.00 0.00 0.08 0.08 0.24 0.00 0.01
Financial Leverage
0.16 0.55 0.31 -0.25 -0.37 -0.24 -0.07 0.01 0.09 0.14 0.00
Leverage Ratio
1.70 2.50 1.97 1.24 1.27 1.35 1.40 1.39 1.49 1.63 1.46
Compound Leverage Factor
1.81 2.71 2.59 1.39 1.55 1.42 1.22 1.30 1.52 1.48 1.45
Debt to Total Capital
36.96% 67.36% 3.78% 2.57% 0.85% 0.43% 8.73% 7.57% 19.85% 0.67% 3.37%
Short-Term Debt to Total Capital
16.21% 47.96% 3.20% 2.02% 0.66% 0.39% 1.25% 0.29% 0.56% 0.62% 2.66%
Long-Term Debt to Total Capital
20.75% 19.40% 0.57% 0.56% 0.19% 0.04% 7.47% 7.28% 19.28% 0.05% 0.72%
Preferred Equity to Total Capital
0.00% 0.00% 0.01% 0.01% 0.00% 0.00% 0.00% 0.01% 0.01% 0.01% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
63.04% 32.64% 96.22% 97.42% 99.15% 99.56% 91.27% 92.42% 80.14% 99.32% 96.62%
Debt to EBITDA
28.11 -5.12 7.24 1.18 0.08 0.09 0.48 0.39 -0.33 0.01 0.07
Net Debt to EBITDA
2.23 -3.90 -32.47 -15.48 -4.46 -4.30 -0.05 -0.18 -0.23 -0.19 -0.05
Long-Term Debt to EBITDA
15.78 -1.48 1.10 0.26 0.02 0.01 0.41 0.37 -0.32 0.00 0.02
Debt to NOPAT
-2.80 -2.64 -0.25 -0.58 7.83 -0.08 2.80 1.30 -0.31 0.04 0.19
Net Debt to NOPAT
-0.22 -2.01 1.13 7.56 -418.49 3.54 -0.29 -0.62 -0.21 -0.54 -0.14
Long-Term Debt to NOPAT
-1.57 -0.76 -0.04 -0.13 1.77 -0.01 2.40 1.25 -0.30 0.00 0.04
Altman Z-Score
0.76 -1.05 3.05 3.74 3.10 2.31 2.13 1.75 -1.47 2.37 3.56
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.01% 0.01% 0.01% 0.00% 0.01% 0.01% 0.01% 0.01% 0.01%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.89 0.53 2.07 3.20 2.77 1.54 1.20 1.55 1.00 1.27 1.05
Quick Ratio
1.78 0.49 1.91 2.68 2.42 1.14 0.89 1.21 0.65 0.92 0.75
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-0.64 -8.16 -2.22 -11 1.98 -66 -12 5.43 15 13 2.91
Operating Cash Flow to CapEx
-446.31% -191.92% 40.40% 662.53% 297.81% -11.51% 126.22% 817.27% 504.77% 1,216.38% 597.76%
Free Cash Flow to Firm to Interest Expense
-2.20 -11.97 -1.68 -32.01 5.18 -134.91 -27.39 13.41 12.27 14.09 10.12
Operating Cash Flow to Interest Expense
-6.53 -1.30 0.21 19.40 19.89 -1.83 29.31 52.22 12.95 22.94 99.52
Operating Cash Flow Less CapEx to Interest Expense
-7.99 -1.98 -0.31 16.47 13.21 -17.71 6.09 45.83 10.38 21.05 82.87
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.93 0.89 1.18 1.38 1.24 1.08 1.00 1.00 1.09 1.48 1.51
Accounts Receivable Turnover
8.78 7.46 7.71 8.98 8.97 11.00 9.59 8.73 8.77 8.98 8.65
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 167.42 0.00 0.00
Fixed Asset Turnover
16.39 16.54 21.39 31.42 27.19 26.85 27.04 26.54 22.57 20.90 18.45
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 12.34 0.00 0.00
Days Sales Outstanding (DSO)
41.57 48.95 47.32 40.66 40.68 33.18 38.05 41.80 41.62 40.66 42.21
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.18 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 29.58 0.00 0.00
Cash Conversion Cycle (CCC)
41.57 48.95 47.32 40.66 40.68 33.18 38.05 41.80 14.21 40.66 42.21
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
16 18 17 27 25 85 101 102 54 50 59
Invested Capital Turnover
1.36 1.44 1.78 2.28 2.49 1.91 1.50 1.37 1.50 2.12 2.21
Increase / (Decrease) in Invested Capital
-2.49 2.63 -0.95 9.46 -1.94 60 16 0.97 -48 -3.75 8.23
Enterprise Value (EV)
14 19 27 32 30 99 93 39 31 55 122
Market Capitalization
13 7.47 30 45 50 120 94 43 24 59 124
Book Value per Share
$1.35 $0.69 $1.76 $3.29 $3.51 $7.68 $6.58 $6.68 $2.63 $3.06 $1.40
Tangible Book Value per Share
$0.05 ($1.06) $0.47 $1.66 $1.98 $1.67 $0.40 $0.72 ($0.16) $0.73 $0.21
Total Capital
24 22 21 40 43 102 107 110 52 50 62
Total Debt
8.73 15 0.80 1.03 0.37 0.44 9.36 8.33 10 0.34 2.08
Total Long-Term Debt
4.90 4.20 0.12 0.22 0.08 0.04 8.02 8.01 10 0.03 0.44
Net Debt
0.69 11 -3.57 -13 -20 -20 -0.98 -3.97 7.00 -4.81 -1.54
Capital Expenditures (CapEx)
0.42 0.46 0.70 1.03 2.56 7.75 11 2.59 3.06 1.70 4.78
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.92 -0.51 0.92 4.25 0.11 -4.73 -3.00 0.28 -3.10 0.39 -0.67
Debt-free Net Working Capital (DFNWC)
8.96 2.97 5.28 19 20 16 7.34 13 0.24 5.53 2.95
Net Working Capital (NWC)
5.13 -7.42 4.61 18 20 16 6.00 12 -0.06 5.22 1.32
Net Nonoperating Expense (NNE)
1.57 3.27 2.40 0.36 0.92 3.02 0.51 0.97 16 1.09 0.34
Net Nonoperating Obligations (NNO)
0.85 11 -2.82 -12 -18 -16 2.88 0.09 12 0.63 -0.87
Total Depreciation and Amortization (D&A)
4.60 5.11 4.30 2.91 4.96 13 16 16 17 16 17
Debt-free, Cash-free Net Working Capital to Revenue
3.97% -2.09% 2.89% 8.40% 0.18% -4.50% -2.15% 0.20% -2.64% 0.35% -0.55%
Debt-free Net Working Capital to Revenue
38.81% 12.11% 16.60% 37.04% 31.20% 15.41% 5.26% 9.06% 0.20% 4.99% 2.45%
Net Working Capital to Revenue
22.22% -30.29% 14.48% 35.44% 30.76% 15.03% 4.30% 8.83% -0.05% 4.71% 1.09%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($0.69) ($0.59) ($0.60) ($1.79) ($0.77) ($0.67) ($4.11) $0.00 $0.10
Adjusted Weighted Average Basic Shares Outstanding
10.33M 10.42M 11.67M 12.01M 12.34M 14.05M 15.04M 15.11M 15.67M 0.00 37.79M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($0.69) ($0.59) ($0.60) ($1.79) ($0.77) $0.00 ($4.11) $0.00 $0.10
Adjusted Weighted Average Diluted Shares Outstanding
10.33M 10.42M 11.67M 12.01M 12.34M 14.05M 15.04M 15.51M 15.67M 0.00 37.95M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 ($0.69) ($0.59) ($0.60) ($1.79) ($0.77) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
9.73M 10.04M 11.01M 11.72M 12.09M 12.68M 14.54M 15.51M 16.12M 0.00 42.49M
Normalized Net Operating Profit after Tax (NOPAT)
-4.37 -6.03 -2.87 -1.73 -0.04 -5.82 2.86 4.51 -2.81 9.52 11
Normalized NOPAT Margin
-18.94% -24.63% -9.01% -3.42% -0.06% -5.53% 2.05% 3.25% -2.40% 8.59% 9.37%
Pre Tax Income Margin
-19.71% -35.11% -17.28% -4.54% -1.05% -8.29% 2.14% 4.04% -41.89% 7.23% 9.13%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-14.87 -11.66 -3.16 -5.82 -1.46 -16.93 7.55 14.75 -40.20 9.80 38.60
NOPAT to Interest Expense
-10.82 -8.11 -2.39 -5.06 0.12 -11.86 7.35 15.81 -27.62 9.93 38.81
EBIT Less CapEx to Interest Expense
-16.33 -12.34 -3.69 -8.75 -8.14 -32.82 -15.67 8.36 -42.76 7.92 21.95
NOPAT Less CapEx to Interest Expense
-12.28 -8.79 -2.92 -7.99 -6.56 -27.75 -15.87 9.42 -30.19 8.05 22.16
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-1.02% -8.06% -26.70% -191.84% -700.57% -129.15% 509.06% 281.92% -29.38% 0.00% 58.30%
Augmented Payout Ratio
-3.62% -14.27% -26.70% -191.84% -700.57% -129.15% 511.88% 282.51% -29.38% 0.00% 58.30%

Quarterly Metrics And Ratios for CareCloud

This table displays calculated financial ratios and metrics derived from CareCloud's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
16,118,492.00 16,120,767.00 16,213,607.00 16,239,777.00 84,633,026.00 42,321,129.00 42,322,039.00 42,397,039.00 42,492,949.00 42,492,949.00 42,493,859.00
DEI Adjusted Shares Outstanding
16,118,492.00 16,120,767.00 16,213,607.00 16,239,777.00 84,633,026.00 42,321,129.00 42,322,039.00 42,397,039.00 42,492,949.00 42,492,949.00 42,493,859.00
DEI Earnings Per Adjusted Shares Outstanding
-0.10 -0.14 -0.04 0.00 -0.01 0.04 0.04 0.04 -0.01 0.00 0.10
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-13.46% -4.33% -2.51% -0.62% 6.43% -2.54% 8.83% 21.90% 13.17% 16.45% 8.56%
EBITDA Growth
26.70% 155.77% 242.89% 118.40% 26.30% 8.86% 7.21% 6.51% -5.47% -9.63% 33.53%
EBIT Growth
166.02% 234.03% 239.01% 107.71% 1,374.26% 49.77% -5.11% -12.64% -49.03% -33.60% 108.37%
NOPAT Growth
157.85% 345.96% 333.70% 111.18% 2,089.79% 33.07% -1.77% -10.91% -52.13% -42.21% 102.27%
Net Income Growth
39.90% 191.38% 213.57% 107.54% 908.30% 73.36% -1.99% -12.38% -52.67% -61.34% 54.48%
EPS Growth
64.29% 62.16% 90.48% 0.00% 60.00% 128.57% 200.00% 0.00% 75.00% -100.00% 150.00%
Operating Cash Flow Growth
297.46% -32.98% 63.88% 39.81% 25.75% 73.12% 4.20% 65.90% -29.38% -4.52% -23.38%
Free Cash Flow Firm Growth
4,996.57% 1,307.18% 1,260.99% -58.11% -90.39% -86.03% -115.87% -172.51% -245.71% -20.43% 369.17%
Invested Capital Growth
-50.14% -48.83% -49.48% -6.92% -5.87% -8.16% 22.94% 16.33% 16.92% -8.44% -25.80%
Revenue Q/Q Growth
-8.64% 8.20% 1.62% -1.08% -2.15% -0.92% 13.48% 10.80% -9.16% 1.95% 5.79%
EBITDA Q/Q Growth
111.91% 34.49% 13.79% 0.97% -18.26% 15.92% 12.06% 0.30% -27.45% 10.81% 65.59%
EBIT Q/Q Growth
100.31% 1,353.68% 68.18% 1.80% -40.77% 47.68% 6.55% -6.28% -65.44% 92.37% 234.38%
NOPAT Q/Q Growth
100.30% 2,357.69% 45.21% 5.92% -42.07% 49.35% 7.19% -3.93% -68.87% 80.31% 275.14%
Net Income Q/Q Growth
99.45% 794.61% 86.50% 5.57% -40.90% 48.97% 5.44% -5.62% -68.07% 21.69% 321.30%
EPS Q/Q Growth
96.71% -40.00% 71.43% 0.00% 0.00% 200.00% 0.00% 50.00% -116.67% 100.00% 0.00%
Operating Cash Flow Q/Q Growth
8.72% 5.24% 65.18% -26.02% -2.22% 44.89% -0.58% 17.79% -58.37% 95.87% -20.22%
Free Cash Flow Firm Q/Q Growth
206.03% -2.39% 1.66% -86.21% -29.80% 41.87% -215.53% 36.98% -41.06% 177.47% 290.81%
Invested Capital Q/Q Growth
-4.11% -1.46% -2.86% 1.42% -3.03% -3.86% 30.04% -4.04% -2.54% -24.71% 5.37%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
41.54% 45.74% 45.98% 262.33% 100.00% 47.11% 47.78% 234.12% 100.00% 45.24% 50.46%
EBITDA Margin
17.97% 22.34% 25.01% 25.53% 21.32% 24.95% 24.64% 22.30% 17.81% 19.36% 30.30%
Operating Margin
0.50% 8.08% 11.44% 12.24% 7.31% 10.94% 10.33% 9.06% 3.20% 5.84% 19.50%
EBIT Margin
0.52% 7.04% 11.65% 11.99% 7.26% 10.82% 10.16% 8.59% 3.27% 6.17% 19.49%
Profit (Net Income) Margin
-0.93% 5.96% 10.94% 11.67% 7.05% 10.60% 9.85% 8.39% 2.95% 3.52% 14.02%
Tax Burden Percent
119.31% 97.72% 98.70% 98.77% 97.94% 98.57% 98.61% 97.53% 94.66% 91.67% 97.38%
Interest Burden Percent
-148.53% 86.65% 95.13% 98.58% 99.20% 99.43% 98.35% 100.14% 95.30% 62.26% 73.84%
Effective Tax Rate
0.00% 2.28% 1.30% 1.23% 2.06% 1.43% 1.39% 2.47% 5.34% 8.33% 2.62%
Return on Invested Capital (ROIC)
0.50% 11.68% 16.93% 25.63% 15.98% 24.57% 21.03% 19.53% 7.09% 15.30% 46.84%
ROIC Less NNEP Spread (ROIC-NNEP)
-3.50% 4.10% 15.43% 23.83% 14.84% 33.35% 17.77% 146.08% 7.85% 8.23% 33.95%
Return on Net Nonoperating Assets (RNNOA)
-0.42% 0.43% 1.54% 3.40% 0.81% -0.39% 1.11% -0.32% -0.45% 1.85% 10.98%
Return on Equity (ROE)
0.09% 12.11% 18.46% 29.03% 16.78% 24.18% 22.13% 19.20% 6.64% 17.15% 57.82%
Cash Return on Invested Capital (CROIC)
24.96% 24.59% 29.84% 24.26% 27.55% 32.08% 0.19% 5.33% 3.47% 28.57% 52.39%
Operating Return on Assets (OROA)
0.57% 7.83% 13.15% 17.78% 10.85% 16.20% 14.40% 13.00% 5.06% 9.38% 28.81%
Return on Assets (ROA)
-1.01% 6.63% 12.35% 17.31% 10.54% 15.88% 13.96% 12.70% 4.57% 5.35% 20.72%
Return on Common Equity (ROCE)
0.09% 12.11% 18.46% 29.03% 16.78% 24.18% 22.13% 19.20% 6.64% 17.15% 57.82%
Return on Equity Simple (ROE_SIMPLE)
-117.13% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
0.09 2.22 3.22 3.41 1.98 2.95 3.17 3.04 0.95 1.71 6.40
NOPAT Margin
0.35% 7.90% 11.29% 12.09% 7.16% 10.79% 10.19% 8.83% 3.03% 5.35% 18.99%
Net Nonoperating Expense Percent (NNEP)
4.00% 7.58% 1.50% 1.80% 1.13% -8.78% 3.25% -126.55% -0.76% 7.08% 12.89%
Return On Investment Capital (ROIC_SIMPLE)
0.18% 4.59% 6.85% 6.81% 3.64% 5.21% 4.84% 4.94% 1.58% 3.05% 12.91%
Cost of Revenue to Revenue
58.46% 54.26% 54.02% -162.33% 0.00% 52.89% 52.22% -134.12% 0.00% 54.76% 49.54%
SG&A Expenses to Revenue
14.33% 14.34% 15.34% 229.60% 71.64% 15.92% 15.73% 201.22% 71.46% 16.84% 14.68%
R&D to Revenue
3.52% 3.76% 2.80% 3.59% 4.47% 3.73% 5.10% 7.39% 7.73% 6.88% 3.12%
Operating Expenses to Revenue
41.04% 37.65% 34.54% 250.09% 92.69% 36.17% 37.44% 225.06% 96.80% 39.40% 30.96%
Earnings before Interest and Taxes (EBIT)
0.14 1.98 3.33 3.39 2.01 2.96 3.16 2.96 1.02 1.97 6.57
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
4.67 6.27 7.14 7.21 5.89 6.83 7.65 7.68 5.57 6.17 10
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.45 0.72 0.92 1.19 1.09 1.78 2.35 2.08 2.66 5.18 3.83
Price to Tangible Book Value (P/TBV)
0.00 12.11 5.94 5.00 3.25 4.67 22.15 13.61 14.93 0.00 0.00
Price to Revenue (P/Rev)
0.17 0.28 0.39 0.54 0.52 0.89 1.19 1.03 1.25 0.70 0.66
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 5,875.17 57.11 31.81 35.97 30.48 15.91
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.02% 1.75% 3.14% 2.78% 3.28% 6.29%
Enterprise Value to Invested Capital (EV/IC)
0.46 0.65 0.82 1.08 1.07 1.92 2.27 2.09 2.68 2.68 2.40
Enterprise Value to Revenue (EV/Rev)
0.21 0.30 0.37 0.49 0.46 0.81 1.21 1.01 1.23 0.90 0.83
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 2.16 1.97 3.33 5.02 4.36 5.52 4.26 3.68
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 6.19 4.88 7.71 12.03 11.04 15.15 12.67 8.71
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 6.11 4.82 7.79 12.03 10.98 15.14 12.97 9.00
Enterprise Value to Operating Cash Flow (EV/OCF)
1.28 2.04 2.12 2.65 2.41 3.63 5.51 4.28 5.65 4.32 4.36
Enterprise Value to Free Cash Flow (EV/FCFF)
1.22 1.80 1.84 4.31 3.76 5.72 1,288.07 42.08 83.24 8.97 3.91
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.22 0.12 0.01 0.01 0.00 0.01 0.13 0.03 0.03 2.22 1.19
Long-Term Debt to Equity
0.22 0.12 0.00 0.00 0.00 0.00 0.12 0.01 0.00 2.20 1.18
Financial Leverage
0.12 0.11 0.10 0.14 0.05 -0.01 0.06 0.00 -0.06 0.23 0.32
Leverage Ratio
1.49 1.47 1.46 1.63 1.57 1.50 1.55 1.46 1.42 2.30 2.21
Compound Leverage Factor
-2.21 1.27 1.39 1.61 1.56 1.49 1.52 1.46 1.36 1.43 1.63
Debt to Total Capital
18.18% 10.55% 1.14% 0.67% 0.37% 1.12% 11.70% 3.37% 2.87% 68.94% 54.37%
Short-Term Debt to Total Capital
0.33% 0.14% 1.08% 0.62% 0.33% 0.97% 1.41% 2.66% 2.46% 0.71% 0.52%
Long-Term Debt to Total Capital
17.85% 10.41% 0.06% 0.05% 0.04% 0.15% 10.28% 0.72% 0.42% 68.22% 53.85%
Preferred Equity to Total Capital
0.01% 0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
81.81% 89.44% 98.85% 99.32% 99.62% 98.87% 88.30% 96.62% 97.12% 31.06% 45.63%
Debt to EBITDA
-0.31 -0.20 -0.03 0.01 0.01 0.02 0.28 0.07 0.06 1.43 0.91
Net Debt to EBITDA
-0.17 -0.09 0.11 -0.19 -0.25 -0.36 0.09 -0.05 -0.08 0.93 0.75
Long-Term Debt to EBITDA
-0.30 -0.19 0.00 0.00 0.00 0.00 0.24 0.02 0.01 1.41 0.90
Debt to NOPAT
-0.28 -0.17 -0.02 0.04 0.02 0.06 0.67 0.19 0.17 4.34 2.23
Net Debt to NOPAT
-0.15 -0.08 0.08 -0.54 -0.61 -0.85 0.22 -0.14 -0.21 2.84 1.84
Long-Term Debt to NOPAT
-0.28 -0.17 0.00 0.00 0.00 0.01 0.58 0.04 0.02 4.30 2.20
Altman Z-Score
0.44 0.83 1.42 2.12 2.40 3.83 3.04 3.26 3.90 1.35 1.72
Noncontrolling Interest Sharing Ratio
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.02 1.03 1.03 1.27 1.69 1.91 1.26 1.05 1.11 1.02 0.87
Quick Ratio
0.68 0.68 0.67 0.92 1.22 1.48 0.84 0.75 0.79 0.82 0.65
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
52 51 52 7.16 5.03 7.13 -8.24 -5.19 -7.32 5.67 22
Operating Cash Flow to CapEx
1,364.43% 3,369.29% 2,116.17% 557.46% 819.39% 637.52% 847.53% 408.62% 876.46% 1,347.24% 1,720.43%
Free Cash Flow to Firm to Interest Expense
143.29 177.25 289.91 105.27 86.64 104.84 -56.03 -370.78 -126.25 6.96 12.31
Operating Cash Flow to Interest Expense
11.14 14.86 39.49 76.90 88.16 108.94 50.10 619.64 62.26 8.68 3.13
Operating Cash Flow Less CapEx to Interest Expense
10.32 14.42 37.62 63.10 77.40 91.85 44.19 468.00 55.16 8.03 2.95
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.09 1.11 1.13 1.48 1.50 1.50 1.42 1.51 1.55 1.52 1.48
Accounts Receivable Turnover
8.49 8.89 9.11 8.98 8.69 8.38 8.36 8.65 8.52 9.28 8.24
Inventory Turnover
182.25 146.06 126.64 0.00 0.00 118.37 109.33 0.00 0.00 5.99 6.20
Fixed Asset Turnover
22.70 22.80 21.74 20.90 20.91 20.54 20.40 18.45 19.42 19.66 19.97
Accounts Payable Turnover
12.22 12.36 10.64 0.00 0.00 12.49 9.98 0.00 0.00 0.58 0.54
Days Sales Outstanding (DSO)
43.02 41.04 40.06 40.66 41.98 43.54 43.65 42.21 42.86 39.31 44.31
Days Inventory Outstanding (DIO)
2.00 2.50 2.88 0.00 0.00 3.08 3.34 0.00 0.00 60.94 58.88
Days Payable Outstanding (DPO)
29.87 29.54 34.31 0.00 0.00 29.21 36.58 0.00 0.00 630.57 679.87
Cash Conversion Cycle (CCC)
15.15 14.00 8.63 40.66 41.98 17.42 10.41 42.21 42.86 -530.32 -576.67
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
52 51 50 50 49 47 61 59 57 43 45
Invested Capital Turnover
1.45 1.48 1.50 2.12 2.23 2.28 2.06 2.21 2.34 2.86 2.47
Increase / (Decrease) in Invested Capital
-52 -49 -49 -3.75 -3.05 -4.18 11 8.23 8.27 -3.97 -16
Enterprise Value (EV)
24 33 41 55 52 90 138 122 153 115 109
Market Capitalization
19 31 43 59 59 100 136 124 155 90 87
Book Value per Share
$2.57 $2.68 $2.87 $3.06 $1.28 $1.33 $1.37 $1.40 $1.37 $0.41 $0.53
Tangible Book Value per Share
($0.06) $0.16 $0.44 $0.73 $0.43 $0.50 $0.14 $0.21 $0.24 ($0.69) ($0.55)
Total Capital
51 48 47 50 54 57 65 62 60 56 50
Total Debt
9.20 5.10 0.54 0.34 0.20 0.64 7.66 2.08 1.73 39 27
Total Long-Term Debt
9.04 5.03 0.03 0.03 0.02 0.09 6.73 0.44 0.25 38 27
Net Debt
5.06 2.48 -2.25 -4.81 -6.60 -9.80 2.58 -1.54 -2.13 25 22
Capital Expenditures (CapEx)
0.30 0.13 0.33 0.94 0.62 1.16 0.87 2.12 0.41 0.53 0.33
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-3.50 -1.88 -1.54 0.39 5.04 4.96 1.91 -0.67 0.25 -12 -8.62
Debt-free Net Working Capital (DFNWC)
0.64 0.74 1.24 5.53 12 15 6.99 2.95 4.10 1.10 -3.98
Net Working Capital (NWC)
0.47 0.67 0.73 5.22 12 15 6.06 1.32 2.63 0.70 -4.24
Net Nonoperating Expense (NNE)
0.33 0.55 0.10 0.12 0.03 0.05 0.11 0.15 0.02 0.58 1.68
Net Nonoperating Obligations (NNO)
11 7.92 3.19 0.63 -5.30 -9.09 3.30 -0.87 -1.18 26 23
Total Depreciation and Amortization (D&A)
4.53 4.30 3.81 3.82 3.89 3.87 4.50 4.72 4.55 4.21 3.65
Debt-free, Cash-free Net Working Capital to Revenue
-3.09% -1.68% -1.39% 0.35% 4.48% 4.44% 1.67% -0.55% 0.20% -9.56% -6.57%
Debt-free Net Working Capital to Revenue
0.57% 0.66% 1.12% 4.99% 10.53% 13.78% 6.11% 2.45% 3.31% 0.85% -3.03%
Net Working Capital to Revenue
0.42% 0.60% 0.66% 4.71% 10.37% 13.28% 5.30% 1.09% 2.12% 0.54% -3.23%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.02) ($0.14) ($0.04) $0.00 ($0.04) $0.04 $0.04 $0.06 ($0.01) $0.00 $0.10
Adjusted Weighted Average Basic Shares Outstanding
16.01M 16.13M 16.20M 16.15M 23.81M 42.32M 42.37M 37.79M 42.47M 42.49M 42.53M
Adjusted Diluted Earnings per Share
($0.02) ($0.14) ($0.04) $0.00 ($0.04) $0.04 $0.04 $0.06 ($0.01) $0.00 $0.10
Adjusted Weighted Average Diluted Shares Outstanding
16.01M 16.13M 16.20M 16.15M 23.81M 42.32M 42.37M 37.95M 42.47M 42.49M 42.53M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
16.12M 16.21M 16.24M 42.32M 42.32M 42.32M 42.40M 42.49M 42.49M 42.49M 42.55M
Normalized Net Operating Profit after Tax (NOPAT)
0.32 2.33 3.29 3.50 2.09 2.98 3.18 3.04 1.00 1.68 6.37
Normalized NOPAT Margin
1.22% 8.30% 11.52% 12.41% 7.56% 10.87% 10.24% 8.83% 3.20% 5.26% 18.89%
Pre Tax Income Margin
-0.78% 6.10% 11.08% 11.82% 7.20% 10.75% 9.99% 8.60% 3.11% 3.84% 14.39%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.37 6.86 18.58 49.78 34.57 43.54 21.46 211.21 17.62 2.41 3.65
NOPAT to Interest Expense
0.25 7.71 18.00 50.20 34.09 43.43 21.53 217.22 16.32 2.09 3.56
EBIT Less CapEx to Interest Expense
-0.44 6.42 16.71 35.99 23.81 26.46 15.55 59.57 10.52 1.77 3.47
NOPAT Less CapEx to Interest Expense
-0.57 7.26 16.14 36.41 23.33 26.34 15.62 65.58 9.22 1.45 3.37
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-21.49% -14.49% -6.67% 0.00% 17.23% 29.44% 43.02% 58.30% 66.32% 117.79% 87.46%
Augmented Payout Ratio
-21.49% -14.49% -6.67% 0.00% 17.23% 29.44% 43.02% 58.30% 66.32% 117.79% 87.46%

Financials Breakdown Chart

Key Financial Trends

CareCloud’s latest results show improving revenue and positive operating cash flow, but the balance sheet has become considerably more leveraged. Q2 2026 revenue increased to $31.9 million, up 16.5% from $27.4 million in Q2 2025 and 2.0% sequentially from Q1 2026. However, gross margin declined to approximately 45.2% from 47.1% a year earlier, while operating margin fell to 5.8% from 11.0%.

CareCloud remained profitable at the consolidated level, reporting $1.1 million of net income. Yet preferred stock dividends of $941,000 left only $181,000 attributable to common shareholders. This compares with a $443,000 loss attributable to common shareholders in Q1 2026 but $1.5 million of common earnings in Q2 2025.

Cash generation was a clear strength in the quarter. Operating cash flow rose to $7.1 million from $3.6 million in Q1 2026, although it was slightly below the $7.4 million reported in Q2 2025. Cash and equivalents increased sharply to $13.4 million from $3.4 million at the end of Q1, helped by reported financing activity. Investors should note that the cash flow statement shows a positive $4.5 million from financing despite listing dividend payments, debt repayments and other financing outflows, making the underlying financing activity worth reviewing in the company’s filing.

  • Revenue growth has reaccelerated: Q2 2026 revenue of $31.9 million was the highest among the comparable quarterly figures provided and was 16.5% above Q2 2025.
  • Operating cash flow remains consistently positive: CareCloud generated $7.1 million in Q2 2026 and has produced positive operating cash flow in every listed quarter since Q3 2023.
  • Sequential cash generation improved: Operating cash flow nearly doubled from $3.6 million in Q1 2026 to $7.1 million in Q2, while net cash increased by $9.5 million during the quarter.
  • Profitability improved from the prior quarter: Operating income increased from $1.0 million in Q1 2026 to $1.9 million in Q2, and common shareholders moved from a $443,000 loss to $181,000 of earnings.
  • Accounts receivable declined: Receivables fell to $14.1 million from $15.3 million at the end of Q1 2026, which may indicate improved collections or working-capital management.
  • Reported cash increased substantially: Cash and equivalents reached $13.4 million, but the increase was accompanied by a reported positive financing contribution and should be reconciled with the detailed filing.
  • Acquisition and investment spending continues: Investing cash outflows totaled $2.0 million in Q2 2026, including $681,000 of acquisitions, $525,000 of capital expenditures and $800,000 of other investing activity.
  • Debt increased sharply: Total short- and long-term debt rose to approximately $38.6 million from $1.7 million at the end of Q1 2026 and $638,000 at the end of Q2 2025.
  • Liquidity has tightened: The current ratio was approximately 1.02 at June 30, 2026, down from 1.11 in Q1 2026 and 1.91 a year earlier. Current liabilities of $33.5 million nearly matched current assets of $34.2 million.
  • Common-shareholder returns remain pressured: Preferred dividends consumed most of consolidated net income in Q2, while the company paid $4.5 million of cash dividends. Retained earnings remained negative at approximately $53.8 million.

The balance sheet also contains meaningful asset-quality and leverage risks. Goodwill and intangible assets totaled approximately $46.8 million, or roughly half of total assets, while total liabilities represented about 81% of assets. Although current-quarter earnings and operating cash flow were positive, the combination of lower margins, substantial preferred dividends and newly reported debt leaves less flexibility if revenue growth slows.

Some historical quarterly figures were restated or contain unusual cost-of-revenue classifications, particularly in Q1 and Q4 2025. Investors should therefore place greater weight on the latest reported trends and reconcile the balance sheet and financing cash flows against CareCloud’s most recent regulatory filing.

11/19/26 02:48 AM ETAI Generated. May Contain Errors.

CareCloud Financials - Frequently Asked Questions

According to the most recent income statement we have on file, CareCloud's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

CareCloud's net income appears to be on an upward trend, with a most recent value of $10.80 million in 2025, compared with -$4.69 million in 2015. The previous period was $7.85 million in 2024. Check out CareCloud's forecast to explore projected trends and price targets.

CareCloud's total operating income in 2025 was $11.34 million, based on the following breakdown:
  • Total Gross Profit: $120.50 million
  • Total Operating Expenses: $109.16 million

Over the last 10 years, CareCloud's total revenue changed from $23.08 million in 2015 to $120.50 million in 2025, a change of 422.1%.

In the past 12 quarters, CareCloud's cash and equivalents has ranged from $2.62 million in Q2 2024 to $13.40 million in Q2 2026, and is currently $4.64 million as of their latest financial filing in Q3 2026.

CareCloud had total debt of $2.08 million at the end of 2025, a 518.5% increase from 2024, and a 76.2% decrease since 2015.

Over the last 10 years, CareCloud's book value per share changed from 1.35 in 2015 to 1.40 in 2025, a change of 4.3%.



Financial statements for NASDAQ:CCLD last updated on 11/5/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners